Page 35 - Hal Barron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RUTH SUNDERLAND: It's not a great look for Elliott to park its tanks on lawn of yet another of Britain's most prominent female bosses In recent years, three of the companies Elliott has targeted in the UK have been run by women  Walmsley does not trade on her gender and plenty of male bosses have found themselves in the sights of activists, including Barclays CEO Jes Staley  It's possible companies run by women are subliminally perceived as more vulnerable - of course that is not true

Benlysta approved for adult patients with active lupus nephritis in Europe 2 The indication of Benlysta (belimumab) was extended after it significantly improved renal outcomes in those with active lupus nephritis. The European Commission (EC) has approved the expanded use of intravenous (IV) and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis (LN), in addition to systemic lupus erythematosus (SLE). Dr Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline (developer of...

EC clears GSK's Benlysta for lupus nephritis 6th May 2021 The European Commission approved expanded use of GlaxoSmithKline’s intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis (LN). The drug is already on the market to treat systemic lupus erythematosus (SLE); this latest approval now provides physicians and patients in Europe with the first and only biologic treatment specifically designed to work in lupus and LN. “Active lupus nephritis, which causes inflammation in the kidneys, is one of th...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Investegate announcements from GlaxoSmithKline PLC, Result of AGM